文献速递慢阻肺

吸烟者死亡原因及临床特征随肺功能受损程度的变化

Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

研究基于COPDGene队列中10,132名现吸烟或曾吸烟者,按肺功能分为正常、PRISm、GOLD 1-2和GOLD 3-4四组,中位随访10.1年发生2,200例死亡。结果显示死亡原因随肺功能受损程度不同:PRISm组心血管死亡最多(31%),GOLD 1-2组肺癌死亡最多(18%),GOLD 3-4组呼吸相关死亡占主导。圣乔治呼吸问卷评分≥25与全因死亡率升高相关,且不受肺功能分组影响。

要点

  • 吸烟者死亡原因随肺功能受损程度不同,PRISm以心血管死亡为主,GOLD 1-2以肺癌死亡为主,GOLD 3-4以呼吸死亡为主。
  • 圣乔治呼吸问卷评分≥25与所有肺功能组的全因死亡率升高相关。
  • 呼吸道急性加重史与GOLD 1-2和GOLD 3-4组死亡率升高相关。

核心结论

  • 吸烟者主要死亡原因随肺功能受损程度而变化。
  • 呼吸相关生活质量越差,全因死亡率越高,且不受肺功能状态影响。

研究设计与样本

  • 研究纳入COPDGene队列中的现吸烟和曾吸烟者,按肺功能分为正常肺功能、PRISm、GOLD 1-2 COPD和GOLD 3-4 COPD四组。
  • 通过纵向随访和社会保障死亡索引确定死亡,并经死亡证明、病历和亲属访谈判定死因。
  • 采用多变量Cox比例风险模型检验基线临床变量与全因死亡率的关联。
  • 共纳入10,132名参与者(年龄59.5±9.0岁;46.6%为女性),中位随访10.1年期间发生2,200例死亡。

主要发现

  • PRISm组心血管疾病死亡最常见,占该组死亡的31%。
  • GOLD 1-2组肺癌死亡最常见,占该组死亡的18%,其他组为9-11%。
  • GOLD 3-4组呼吸相关死亡超过其他竞争性死因,尤其当BODE指数≥7时。
  • 圣乔治呼吸问卷评分≥25与全因死亡率升高相关:正常肺功能组HR 1.48(1.20-1.84);PRISm组HR 1.40(1.05-1.87);GOLD 1-2组HR 1.80(1.49-2.17);GOLD 3-4组HR 1.65(1.26-2.17)。
  • 呼吸道急性加重史与GOLD 1-2和GOLD 3-4组死亡率升高相关;定量肺气肿与GOLD 1-2组死亡率升高相关;气道壁增厚与PRISm和GOLD 3-4组死亡率升高相关。

临床怎么用

  • 对吸烟者应结合肺功能受损程度评估主要死亡风险,并针对性筛查和管理。
  • 圣乔治呼吸问卷评分≥25可作为识别全因死亡高风险吸烟者的指标,不受肺功能分组限制。
  • 对GOLD 1-2和GOLD 3-4组应关注呼吸道急性加重史,对PRISm和GOLD 3-4组应关注气道壁增厚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Cigarette smoking contributes to the risk of death through different mechanisms. Objectives: To determine how causes of and clinical features associated with death vary in tobacco cigarette users by lung function impairment. Methods: We stratified current and former tobacco cigarette users enrolled in Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) into normal spirometry, PRISm (Preserved Ratio Impaired Spirometry), Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1-2 COPD, and GOLD 3-4 COPD. Deaths were identified via longitudinal follow-up and Social Security Death Index search. Causes of death were adjudicated after a review of death certificates, medical records, and next-of-kin interviews. We tested associations between baseline clinical variables and all-cause mortality using multivariable Cox proportional hazards models. Measurements and Main Results: Over a 10.1-year median follow-up, 2,200 deaths occurred among 10,132 participants (age 59.5 ± 9.0 yr; 46.6% women). Death from cardiovascular disease was most frequent in PRISm (31% of deaths). Lung cancer deaths were most frequent in GOLD 1-2 (18% of deaths vs. 9-11% in other groups). Respiratory deaths outpaced competing causes of death in GOLD 3-4, particularly when BODE index ⩾7. St. George's Respiratory Questionnaire score ⩾25 was associated with higher mortality in all groups: Hazard ratio (HR), 1.48 (1.20-1.84) normal spirometry; HR, 1.40 (1.05-1.87) PRISm; HR, 1.80 (1.49-2.17) GOLD 1-2; HR, 1.65 (1.26-2.17) GOLD 3-4. History of respiratory exacerbations was associated with higher mortality in GOLD 1-2 and GOLD 3-4, quantitative emphysema in GOLD 1-2, and airway wall thickness in PRISm and GOLD 3-4. Conclusions: Leading causes of death vary by lung function impairment in tobacco cigarette users. Worse respiratory-related quality of life is associated with all-cause mortality regardless of lung function.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Labaki WW, Gu T, Murray S, et al. Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment. Am J Respir Crit Care Med. 2023. PMID: 37159910. doi:10.1164/rccm.202210-1887OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。